Treatment of Resectable Gallbladder Cancer
- PMID: 35326566
- PMCID: PMC8945892
- DOI: 10.3390/cancers14061413
Treatment of Resectable Gallbladder Cancer
Abstract
Gallbladder cancer (GBC) is the most common biliary tract cancer worldwide and its incidence has significant geographic variation. A unique combination of predisposing factors includes genetic predisposition, geographic distribution, female gender, chronic inflammation, and congenital developmental abnormalities. Today, incidental GBC is the most common presentation of resectable gallbladder cancer, and surgery (minimally invasive or open) remains the only curative treatment available. Encouragingly, there is an important emerging role for systemic treatment for patients who have R1 resection or present with stage III-IV. In this article, we describe the pathogenesis, surgical and systemic treatment, and prognosis.
Keywords: gallbladder cancer; incidental; oncologic extended resection; resectable; treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Managing the incidentally detected gallbladder cancer: algorithms and controversies.Int J Surg. 2014;12 Suppl 2:S108-S119. doi: 10.1016/j.ijsu.2014.08.367. Epub 2014 Aug 23. Int J Surg. 2014. PMID: 25182380
-
Gallbladder cancer.Curr Treat Options Gastroenterol. 2006 Apr;9(2):95-106. doi: 10.1007/s11938-006-0028-1. Curr Treat Options Gastroenterol. 2006. PMID: 16539870
-
Minimally Invasive Surgery for Gallbladder Cancer.Surg Oncol Clin N Am. 2019 Apr;28(2):243-253. doi: 10.1016/j.soc.2018.11.001. Epub 2019 Feb 2. Surg Oncol Clin N Am. 2019. PMID: 30851826 Review.
-
Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.World J Gastroenterol. 2012 Aug 14;18(30):4019-27. doi: 10.3748/wjg.v18.i30.4019. World J Gastroenterol. 2012. PMID: 22912553 Free PMC article.
-
Current management of incidental gallbladder cancer: A review.Int J Surg. 2022 Feb;98:106234. doi: 10.1016/j.ijsu.2022.106234. Epub 2022 Jan 21. Int J Surg. 2022. PMID: 35074510 Review.
Cited by
-
Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study.Ann Surg Oncol. 2023 Aug;30(8):4904-4911. doi: 10.1245/s10434-023-13531-2. Epub 2023 May 6. Ann Surg Oncol. 2023. PMID: 37149547 Free PMC article.
-
Residual cancer is a strong predictor of survival in T3 incidental gallbladder cancer.BMC Surg. 2022 Dec 28;22(1):443. doi: 10.1186/s12893-022-01869-5. BMC Surg. 2022. PMID: 36577967 Free PMC article.
-
Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study.World J Surg Oncol. 2024 Oct 1;22(1):263. doi: 10.1186/s12957-024-03533-z. World J Surg Oncol. 2024. PMID: 39354502 Free PMC article.
-
A Single-Center Analysis of Patient Characteristics and Overall Survival in Patients with Resectable Gallbladder Cancer.Healthcare (Basel). 2024 Oct 21;12(20):2091. doi: 10.3390/healthcare12202091. Healthcare (Basel). 2024. PMID: 39451505 Free PMC article.
-
A prognostic model and novel risk classification system for radical gallbladder cancer surgery: A population-based study and external validation.Heliyon. 2024 Aug 2;10(15):e35551. doi: 10.1016/j.heliyon.2024.e35551. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170241 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources